Company / Income Tax
Processa Pharmaceuticals, Inc. Income Tax History
FY2013-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
-$530.6K
FY2022
5-year range
-$1.0M / -$50
FY2018-FY2022
Trend
+47.0%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$100 to -$530,611 over the past 6 years.
Based on SEC 10-K filings.
-$530,611 in FY2022.
Improved from -$100 to -$530,611 over the past 6 years.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, income tax increased 47.0% year-over-year.
- Peak income tax was recorded in FY2014.
- Lowest income tax in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -4.39 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | -$530.6K | +47.0% |
| FY2021 | -$1.0M | -1000919.0% |
| FY2016 | -$100 | +0.0% |
| FY2015 | -$100 | -100.0% |
| FY2014 | -$50 | +72.4% |
| FY2013 | -$181 | - |
As of FY2022 · SEC 10-K · Updated Jun 28, 2026